Gyre Therapeutics Inc (GYRE)
$4.55 -28.94% Close Oct 30, 2026 Live
Gyre Therapeutics stock today
Gyre Therapeutics closed at $4.55 on October 30, 2026, down 28.94% on the day. Over the past year it returned -40.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $442 million.
$6.00$8.00
NovJan 2026MarMayJulSep
| Period | GYRE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -37.9% | -0.9% |
| 3 months | -21.6% | +2.1% |
| Year to date | -35.5% | +11.7% |
| 1 year | -40.5% | +12.4% |
| 3 years | -40.6% | +88.5% |
| 5 years | -31.8% | +76.0% |
Key statistics
- Market value
- $442M
- Price / sales
- 3.7
- 52-week range
- $4.55 to $8.76
- Next report
- Nov 5, 2026 (estimated)
About Gyre Therapeutics
Biopharmaceutical company developing therapies for eye diseases and related conditions.
Sector: Health Care
More on Gyre Therapeutics
- Financials: revenue, earnings and segmentsRevenue +10% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $204.77 today
No forecast, no recommendation. This page describes Gyre Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.